Publications

Best Paper awards

2008

A comparison of the drug review process at five international regulatory authorities. 44th Annual DIA Meeting, Boston, USA (June 2008)

2007

Can standard scorecards evaluate the quality of industry submissions and their regulatory assessment? 43rd Annual DIA Meeting, Atlanta, Georgia (June 2007)

2006

The influence of treatment complications on patient reported outcomes in PD. 13th Annual International Society for Quality of Life Research Meeting, Lisbon, Portugal (October 2006).

2005

How do 'go/non go' decisions influence R&D efficiency. 17th Annual Euro DIA Meeting, Lisboa Congress Centre, Lisbon, Portugal (March 2005).
Assessment of health-related quality of life in patients with HIV: is it practical? British Pharmaceutical Conference, Manchester (September 2005)

2002

Depression in People with Parkinson’s Disease. Welsh Primary Care Research and Clinical Effectiveness Symposium (December 2002).
The Impact of Routine Assessment of Information Needs on Patient Outcomes. 19th Annual Conference of the British Psychosocial Oncology Society. Harrogate, North Yorkshire (December 2002).

2001

Review times - is there still room for improvement? DIA Meeting, Colorado, USA (May 2001).

1999

Health-related quality of life assessment in practice. 6th Annual Conference of the International Society of Quality of Life Research, Barcelona, Spain (November 1999).

1997

Provision of patient medication records (PMRs) in community pharmacy in Thailand: Is it acceptable? 26th European Symposium on Clinical Pharmacy, Tors, France (October, 1997) - Health Base Poster Award.

1995

The Experience of Home Dialysis and its Impact on the Informal Carer. 1st Annual Research Meeting of the Welsh School of Pharmacy, Cardiff (May 1995) - poster presentation.

1991

Quality of Life improvement in Cyclosporin treated atopic dermatitis patients - a double-blind crossover study. 71st Annual Meeting of the British Association of Dermatologists, London (July 1991) - oral presentation.

1988

Hypertension and Quality of Life. Pharmaceutical Conference, Ruthin, Wales, U.K. (October 1988) - oral presentation.

Publications

2007

SALEK, M.S. and Lewis, J.J.C. (2007). Responsiveness of a non-modality specific quality of life measure: the Renal Quality of Life Profile (RQLP). Social Indicators Research. Submitted.
Shafie, A.A. and SALEK, M.S. (2007) Economic Evaluation of HAART A Review. PharmacoEconomics. Submitted.
Finlay, I.G., Pratheepawanit, N. & SALEK, M.S. (2007). Using patients’ quality of life to audit the effectiveness of hospice care: is it appropriate? International Journal of Palliative Nursing. Submitted.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (2007). The impact of routine assessment of quality of life on doctor’s behaviour in outpatient consultations. Quality in Health Care. Submitted.
Andrea Mallia-Milanes, A., McAuslane, N., SALEK, S. & Walker, S. (2007) Can systematic use of scorecards be of value in the evaluation of the quality of industry submissions and their regulatory review? 36th European Symposium on Clinical Pharmacy, 25-27 October 2007, Istanbul, Turkey. Submitted.
Morgan, L., SALEK, M.S., McAuslane, N., Read, K. & Walker S. (2007) Companies submission strategies and regulatory approval times greatly influence patient access to medicine. 36th European Symposium on Clinical Pharmacy, 25-27 October 2007, Istanbul, Turkey. Submitted.
SALEK, M.S., Gill, N., Gates, B. (2007) Evaluation of the Effectiveness of Sliding Scale Insulin for Glycemic Control in the Home Care Setting. 36th European Symposium on Clinical Pharmacy, 25-27 October 2007, Istanbul, Turkey. Submitted.
SALEK, M.S., Patel, J. & Schwartz. C. (2007) Evaluation of a rapid streptococcus testing service in the community pharmacy. 36th European Symposium on Clinical Pharmacy, 25-27 October 2007, Istanbul, Turkey. Submitted.
SALEK, M.S., Lewis-Smith, R.E., Ives, T.J. & Rake, K.M. (2007) How prevalent are opioid misuse and affective disorders in patients with fibromyalgia? 36th European Symposium on Clinical Pharmacy, 25-27 October 2007, Istanbul, Turkey. Submitted.
SALEK, M.S., Finlay, A.Y. & Sumner, M.J. (2007). Effect of long-term Cyclosporin treatment on quality of life of adult eczema patients - an open multicentre study. Journal of Applied Therapeutic Research. Submitted.
Pratheepawanit, N., Raetai, K., Weerapreeyakul, T. & SALEK S. Adverse events of chemotherapy only temporarily decrease HRQoL of breast cancer patients: one year follow-up. Proceedings of the 5th Indochina Conference on Pharmaceutical Sciences, 21-24 November 2007, Bangkok, Thailand. Accepted.
SALEK, S., Shafie, S., Evans, R., Freedman, A., Birley, H., Browning, M. & Cohen, D. (2007) Can systematic assessment of patients’ quality of life influence optimisation of HIV treatment? Pharmacy World and Science. 29(5), 490
SALEK, S., Shafie, S., Evans, R., Freedman, A., Birley, H., Browning, M. & Cohen, D. (2007) The case for HRQoL assessment: key to successful HIV treatment. Pharmacy World and Science. 29(5), 491.
SALEK, S., Davies, E., Patel, C. & Finlay, A. (2007) Health related quality of life (HRQoL) discussion in consultations: a key to successful treatment outcomes. Pharmacy World and Science. 29(5), 454
SALEK, S., Suntharasaj. S. & Suntharasaj T. (2007) Conceptualisation of a Menopause-Specific Quality of Life Profile. Pharmacy World and Science. 29(5), 495.
SALEK, S., Sampson, R. & Gilbertson, J. (2007) Optimisation of discharge communication: a key to successful outcome. Pharmacy World and Science. 29(5), 474.
SALEK, S., Chauhan, A., Hirako, M., McAuslane, N. & Walker, S. (2007) Does the global increase in post-marketing commitment ensure faster patient access to novel medicines? Pharmacy World and Science. 29(5), 448
Shenton, C.L., SALEK, S., Dowding, C.H., Raha, S., Ebenezer, L & Sastry, D.B. How do treatment complications affect the health-related quality of life of patients with Parkinson’s disease over time? Quality of Life Research. ISOQOL Conference Abstracts Issue October 2007, A115.
Pratheepawanit, N., Weerapreeyakul, T. and SALEK, S. One year follow-up shows that the adverse events of chemotherapy only temporarily decrease hrqol of breast cancer patients. Quality of Life Research. ISOQOL Conference Abstracts Issue October 2007, A98.
SALEK, S., Edmunds O., Basra, MK & Finlay, AY. (2007) Assessing the convergent validity of a questionnaire used to measure the quality of life of family members of dermatology patients. Quality of Life Research. ISOQOL Conference Abstracts Issue October 2007, A92.
SALEK, MS, Corke L, Ketchell I. (2007) Development of a new adult cystic fibrosis specific quality of life profile. Quality of Life Research. ISOQOL Conference Abstracts Issue October 2007, A123.
Dowding, C.H., SALEK, S.S., Sastry, D.B., Raha, S., Morgan, E., Ebenezer, L., Bater, A & Bayer, A. Electronic capturing of HRQoL in the management of patients with PD. Quality of Life Research. ISOQOL Conference Abstracts Issue October 2007, A44.
Basra, M.K.A., Edmunds, O., SALEK, M.S. & Finlay, A.Y. (2007) Measurement of family impact of skin disease: further validation of the Family Dermatology Life Quality Index (FDLQI). Journal of the European Academy of Dermatology & Venereology. In press.
Davies, E., Patel, C., SALEK, S. & Finlay, A. (2007) Does ad-hoc quality of life discussion in inflammatory skin disease consultations reflect standardised patient reported outcomes? Clinical and Experimental Dermatology. In press.
SALEK M.S., Roberts, A.R., Finlay, A.Y. (2007) The practical reality of using a patient-reported outcome measure in a routine dermatology clinic. Dermatology. 215, 315-319.
Mussen, F., SALEK, M.S. & Walker, S. (2007) Benefit Risk Appraisal of Medicines: A Systematic Approach to Decision-Making. John Wiley & Sons. In press.
van den Haak, M.A., SALEK, M.S. & Walker, S. (2007) An Evaluation of Efficiency And Productivity of the International Pharmaceutical Industry and its Sustainability in the 21st Century. In press.
Lilja, J., Alvarez, A., Hamilton, D. & SALEK, S. (2007) Pharmaceutical Systems - Global Perspectives. In press.
Davies, E., Patel, C., SALEK, M.S. & Finlay, A.Y. (2007) Quality of life discussions in patients with inflammatory skin diseases - a prospective observational study. Journal of the European Academy of Dermatology and Venereology. In press.
Smith, H., SALEK, S. & Cox, W. (2007) Predictors of academic difficulty of students at the University of North Carolina at Chapel Hill School of Pharmacy. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 78.
Patel, J., SALEK, S. & Schwartz, C. (2007) Evaluation of a rapid streptococcus testing service in the community pharmacy. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 66.
Morgan, L., SALEK, S., Read, K., McAuslane, N. & Walker, S. (2007) Evaluation of pharmaceutical company strategy and regulatory review processes and their impact on patient access to new medicines. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 54.
Lewis-Smith, R.E., Ives, T.J., Rake, K.M. & SALEK, S. (2007) Opioid misuse and affective disorders in patients with fibromyalgia. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 43.
Gill, N.K., Gates, B. & SALEK, S. (2007) Assessment of sliding scale insulin in the home care setting. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 23.
Edmunds, E.O., SALEK, S., Finlay, A. & Basra, M. (2007) Assessing the validity of questionnaires used to measure the quality of life of family members of dermatology patients. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 19.
Corke, L., SALEK, S. & Ketchell, I. (2007) Development of a new adult cystic fibrosis specific quality of life profile. In John, DN. (ed) WSP MPharm Research Abstracts 2007, Cardiff University, 16.
SALEK, M.S., Jones, S., Rezai, M., Davies, C., Mills, R.R., Ketchell, R.I. (2007) Are the patient-reported outcomes (PROs) of value in annual review (AR) of adult patients with CF? Journal of Cystic Fibrosis. 6(suppl 1), S77.
Mussen, F., SALEK, M.S. & Walker, S. (2007). A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new model. Commentaries. Pharmacoepidemiology and Drug Safety. 16, S42-S46.
Mussen, F., SALEK, M.S. & Walker, S. (2007). A quantitative approach to benefit-risk assessment of medicines - part 2: The practical application of a new model. Pharmacoepidemiology and Drug Safety. 16, S16-S41.
Mussen, F., SALEK, M.S. & Walker, S. (2007). A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis. Pharmacoepidemiology and Drug Safety. 16, S2-S15.
SALEK S. (2007) Are we using the right outcome measure to ascertain patient benefit from drug therapy? Abstract Book PharmaCon 2007, Dubrovnik, May. 14.
Morgan, L., McAuslane, N., Read, K., SALEK, S., Walker, S. (2007) Is the delay in patient access to medicines a result of company strategy or the review process? Drug Information Journal. 41, 426.
Mallia-Milanes, A., McAuslane, N., SALEK, S., Walker, S. (2007) Can standardised scorecards evaluate the quality of industry submissions and their regulatory assessment? Drug Information Journal. 41, 426.
Tlusta, E., Kubena. A., SALEK, M.S. and Vlcek, J. (2007) Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31). Epilepsy and Behavior. 10, 407-411.
Hirako, M., McAuslane, M., SALEK, S., Anderson, C. & Walker, S. (2007) A comparison of the drug review process at five international regulatory authorities. Drug Information Journal. 41, 291-308.
SALEK, S & Walker M. (2007) Health-related quality of life measurement techniques in the management of dementia. In Gauthier S (ed) Clinical Diagnosis and Management of Alzheimer’s Disease (3rd Ed). Oxon: Informa Healthcare. 351-376.
SALEK S. (2007) Are we using the right outcome measure to ascertain patient benefit from drug therapy? Abstract Book 7th International Saudi Pharmaceutical Conference, March 2007. 36.
SALEK, M.S., Telford, M. & Luscombe, D.K. (2007) Cardiff University/BrAPP Postgraduate Course in Pharmaceutical Medicine. Abstract Book, ICPM Conference, 3-6 September, Seoul, Korea. PM-3. 205.
2006
SALEK, S., Jones, S., Rezai, M., Davies, C., Mills, R. & Ketchell, I. (2006) Comparison of a generic and disease-specific health related quality of life (HRQoL) instrument in adult cystic fibrosis. Pediatric Pulmonology. Suppl 29, 401.
Davies, E., Patel, C., SALEK, S. & Finlay A. (2006) Quality of life discussion and patient satisfaction in inflammatory skin disease consultations. Journal of the American Academy of Dermatology, 54(3), Suppl. AB120.
SALEK, M.S., Patel, C., Davies, E., Finlay, A.Y. (2006) Quality of life in skin disease consultations. Clinical Pharmacy Europe. 4, 43-44.
SALEK, S., Jones, S., Rezaie, M., Davies, C., Mills, R., Ketchell, I. (2006) Health-related quality of life (HRQoL) assessment in adult cystic fibrosis (CF): a CF-specific or a generic measure? Abstract Book. 35th European Symposium on Clinical Pharmacy. Vienna, Austria. 73.
SALEK, S., Carr, I., Hirako, M., McAuslane, N., Walker, S. (2006) An evaluation of international trends in dossier submissions and regulatory review times for new medicines. Abstract Book. 35th European Symposium on Clinical Pharmacy. Vienna, Austria. 65.
Aderounmu, A & SALEK, S. (2006) Evaluating medication-related problems of cardiovascular drugs in 5 community settings using the PCNE-DRP system. Abstract Book. 35th European Symposium on Clinical Pharmacy. Vienna, Austria. 32.
SALEK, S., Roberts, A., Finlay, A. (2006) Does the availability of health-related quality of life (HRQoL) information during consultation influence treatment decision-taking? Abstract Book. 35th European Symposium on Clinical Pharmacy. Vienna, Austria. 24.
Aderounmu, A & SALEK, S. (2006) Development and validation of an instrument to measure socioeconomic impacts of medication-related problems: the socioeconomic impact profile (SEIB). Abstract Book. 35th European Symposium on Clinical Pharmacy. Vienna, Austria. 9.
SALEK, S. (2006) Monitoring self-reported quality of life amongst patients attending a palliative medicine outpatient clinic to aid treatment decision taking. 2006 ISOQOL Research meeting abstracts [www.isoqol.org/2006mtgabstracts]. QLR Journal, A-7, 1654.
SALEK, S., Shafie, A., Evans, R., Freeman, A. (2006) Does presence of meaningful QoL data influence dermatology outpatient consultation? 2006 ISOQOL Research meeting abstracts [www.isoqol.org/2006mtgabstracts]. QLR Journal, A-110, 1546.
SALEK, S., Jones, S., Rezaie, M., Davies, C., Mills, R. & Ketchell, I. (2006) Do patient reported outcomes improve management of adult cystic fibrosis? 2006 ISOQOL Research meeting abstracts [www.isoqol.org/2006mtgabstracts]. QLR Journal, A-32, 1538.
SALEK, S., Roberts, A. & Finlay, A. (2006) Does presence of meaningful QoL data influence dermatology outpatient consultation? 2006 ISOQOL Research meeting abstracts [www.isoqol.org/2006mtgabstracts]. QLR Journal, A-147, 1541.
Shenton, C., SALEK, S., Raha, S., Ebenezer, L., Morgan, E., Pooviah, P., Ikram, Z & Sastry, D. (2006) The influence of treatment complications on patient reported outcomes in PD. 2006 ISOQOL Research meeting abstracts [www.isoqol.org/2006mtgabstracts]. QLR Journal, A-54, 1328
Carr, I., Hirako, M., McAuslane, N., SALEK, M.S. & Walker, S.R. (2006) An evaluation of international trends in dossier submissions and regulatory review times for new medicines. WSP UG 2006 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 9.
Roberts A.R., SALEK, M.S. & Finlay, A.Y. (2006) Does presence of meaningful QoL data influence dermatology outpatient consultation? WSP UG 2006 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 61.
Jones, S., Ketchell, I. & Salek, M.S. (2006) The impact of cystic fibrosis on health-related quality of life. WSP UG 2006 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 44.
Shenton, C., Salek, S., Dowding, C., Raha, S., Ebenezer, L., Morgan, E., Pooviah, P., Ikram, Z., Ahmed S. & Sastry D. (2006) The impact of PD treatment complications on patient HRQoL. Age and Ageing. 35; Supplement 3: i56-i59.
Dowding, C.H., Shenton, C.L. & SALEK, S.S. (2006) A review of the health-related quality of life and economic impact of Parkinson’s disease. Drugs and Aging. 23(9), 693-721.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (2006) Quality of life assessment in routine clinical practice: lesson learned from a two-year study. PRO Newsletter. 36, 25-28.
Chan, W.Y., Setter, S.M, Sclar, D.A., SALEK, S., Corbett, C. & Henriksen, A.L. (2006) The use of anticholinergics in homebound elderly patients with dementia. Consult Pharm. 21(5), 391-399.
Carr, I., Hirako, H., McAuslane, N., SALEK, S. and Walker S. (2006) Has international access to new medicines improved in the post-ICH period? Drug Information Journal. 40, 239.
Andrea Mallia-Milanes, A. SALEK, M. and Walker, S. The role of regulatory quality measures in meeting the 21st century challenges of drug innovation. Drug Information Journal. 2006; 40: 243.
Lua, P.L, Salek, S., Finlay, I., Boay, A. & Said, R.M. (2006) Cross-cultural comparison of health related quality of life (HRQoL) profile in advanced cancer population: United Kingdom versus Malaysia. International Symposium on Oncology Pharmacy Practice X, April 3-6, Kuala Lumpur, Malaysia.
SALEK S. (2006) Medicines Regulation & Pharmacoeconomics: Can you afford not to attend? Pharmaceutical Physician. 16(6), 32-35.
SALEK, S. (2006) Translating the science of quality of life into practice. Abstract Book. 6th Asian Conference on Clinical Pharmacy. July 6th - 9th, Bangkok, Thailand. 89-90.
SALEK, S. (2006) Healthcare marketplace and safety of medicines: important DPM material. Pharmaceutical Physician. 16(5), 18-21.
Dixon, S., Walker, M. & SALEK, S. (2006) Incorporating carer effects into economic evaluation. PharmacoEconomics. 24(1), 43-53.
Shenton, C., Dowding, C., Salek, S., Raha, S., Ebenezer, L., Morgan, E., Pooviah, P., Ikram, Z., & Sastry, D. Assessment of HRQoL in PD and its Impact on Minimising Treatment Complications. Movement Disorders.; The Movement Disorder Society's 10 th International Congress of Parkinson’s Disease and Movement Disorders-Kyoto, Japan. 29th October-2 nd November 2006. 21 (S15); S466 (P508)
2005
Suntharasaj. S., SALEK, S. & Suntharasaj T. (2005) Development of a Thai Menopause-Specific Quality of Life Instrument. Quality of Life Research. 14(9), 2102.
Davies, E., Patel, C., SALEK, M.S. & Finlay, A.Y. (2005) Quality of life discussions in patients with inflammatory skin diseases. Journal of the European Academy of Dermatology and Venereology, 19, (CD ROM).
SALEK, S., Patel, C. Davies, E., & Finlay, A. (2005) Are dermatology outpatient clinic consultations patient-centred? Quality of Life Research. 14(9), 2045.
SALEK S., Varma, K. & Finlay, A.Y. (2005) Minimal Clinical Important Score Changes of Quality of Life Scores in Dermatology. Journal of the European Academy of Dermatology and Venereology. 19, (CD ROM).
SALEK, S., Shafie, A., Evans, R., Freedman, A., Birley, H., Browning, M. & Cohen, D. (2005) Cross-cultural validity and reliability of Health Utility Index (HUI3) in patients with HIV. Quality of Life Research. 14(9). 2153.
Chauhan, A., SALEK, M.S., Hirako, M., McAuslane, J.A.N. & Walker, S. (2005) International comparison of post-marketing commitments 2000-2004. DIA Conference, Washington DC June 2005.
SALEK, M.S. & Finlay, A.Y. (2005). Quality of life in patients with severe psoriasis and the effect of a 12 week course of Cyclosporin. Journal of Applied Therapeutic Research.
Lua, P.L., Salek, M.S., Finlay, I.G., Boay, A.G.I. & Mohd. Said, R. (2005) Translation and cross-cultural adaptation of a quality of life instrument for palliative care use in Malaysia. 2nd-4th Aug 2005 at The Magellan Sutera, Kota Kinabalu, Sabah for the 10th International Conference On Translation.
Lua, P.L., SALEK, S. & Finlay, I. (2005) Quality of life: concept, assessment and cross-cultural issues. Malaysian Journal of Pharmacy.
SALEK, S. (2005) Health economics and access to treatment. In Gunning, J. and Holm, S (Eds) Ethics Law and Society. Aldershot; Ashgate. 59-64.
SALEK, M.S. (2005) Pharmaceutical development and medical statistics - attend or not attend - this is the dilemma. Pharmaceutical Physician. 16(3), 20-21.
David, S.E., Ahmed, Z., Salek M.S. & Finlay, A.Y. (2005) Does enough quality of life related discussion occur during Dermatology outpatient consultations? British Journal of Dermatology. 153, 997-1000.
Hongbo, Y., Thomas, C.L., Harrison, M.A., Salek, M.S. & Finlay, A.Y. (2005) Translating the science of quality of life into practice: what do Dermatology Life Quality Index (DLQI) scores mean? Journal of Investigative Dermatology. 125, 659-664.
Anderson, C., McAuslane, J.A.N., SALEK, S. & Walker, S.R. (2005) Benchmarking approval times of the major international authorities. Drug Information Journal.
SALEK, M.S. (2005) Comparing the Precision of HRQOL Data Relative to other Clinical Measures in Practice. 3rd Spring Symposium. Journal of the European Academy of Dermatology and Venereology. In press.
Shafie, A.A., SALEK, S., Evans, R.H., Freedman, A.R., Birley, H., Browning, M. & Cohen, D. (2005) Assessment of health-related quality of life in patients with HIV: is it practical? The International Journal of Pharmacy Practice. 13. R47.
SALEK, S. (2005) A practical guide to preparation for the Dip Pharm Med exam. Pharmaceutical Physician. 16(2), 22-24.
SALEK, S. (2005) Productivity of the global pharmaceutical industry and its sustainability in the 21st century. Abstract Book of the Third Croatian Congress on Pharmacy. Cavtat, Croatia, April 27th - 30th. 9.
Katugampola, R.P., Thomas, ClC., Hongbo, Y., SALEK, M.S & Finlay, A.Y. (2005) Psoriasis decision taking and the dermatology life quality index bands. British Journal of Dermatology. 153, 475-476.
Lua, P.L., SALEK, S., Finlay, I., Boay, A.G.I. & Mohd. Said, R.(2005) The feasibility, reliability and validity of the Malay McGill Quality Of Life Questionnaire - Cardiff Short Form (MMQOL-CSF) in Malaysian population with advanced cancer. Medical Journal of Malaysia, 6(1), 28-40.
Lua, P.L., SALEK, S., Finlay, I. & Lloyd-Richards, C. (2005) The feasibility, reliability and validity of the McGill Quality Of Life Questionnaire - Cardiff Short Form (MQOL-CSF) in palliative care population. Quality of Life Research, 14, 1669-1681.
SALEK, S. (2005) Thirty years of excellence. Pharmaceutical Physician. 16(1), 28-30.
SALEK, S. (2005) An instrument that hits the right note. Good Clinical Practice Journal. 12(7), 27-30.
van den Haak, M.A., SALEK, S. & Walker, S.R. (2005) How do 'go/non go' decisions influence R&D efficiency. DIA Europe, Lisbon March 2005. Presented at the 17th Annual Euro DIA Meeting, March 7-9, 2005, Lisboa Congress Centre, Lisbon, Portugal.
SALEK, M.S. (2005) Partnerships between pharmaceutical industry and academia. European Association of Faculties of Pharmacy Conference Abstract Book. 9.
SALEK. M.S., David. S., Ahmed. Z., Finlay. A.Y. (2005) Very little quality of life (QoL) related discussion occurs during dermatology outpatient consultations. Pharmacy World & Science. 27(2). A86.
SALEK. M.S., Clark. M.J., McAuslane. J.A.N., & Walker. S. (2005) Assessment of the impact of changes in regulatory environment on approval times in the major markets. Pharmacy World & Science. 27(2). A15.
SALEK. M.S., Chan. W-Y., and Setter. S.M. (2005) Use of anticholinergics in community-dwelling homebound elderly patients with dementia. Pharmacy World & Science. 27(2). A55.
Al-Motarreb, A., Briancon, S., Al-Jaber, N., Al-Adhi, B., Al-Jailani, F., SALEK, M.S. & Broadley, K.J. (2005). Khat chewing is a risk factor for acute myocardial infarction: a case-control study. British Journal of Clinical Pharmacology. 59(9) 574-581.
Shafie, A. A., Salek, M. S., Evans, R. H., Freedman, A. R., Birley, H., Browning, M. and Cohen, D. 2005, ‘Self assessed health-related quality of life among HIV patient in UK’, paper to presented to the ISPOR 8th Annual European Congress, Florence, 6-8 November
Shafie, A. A., Salek, M. S., Evans, R. H., Freedman, A. R., Browning, M., Birley, H. and Cohen, D. 2005, ‘Cross-cultural validity and reliability of Health Utility Index 3 in patients with HIV’, paper presented to the ISOQOL 12th Annual Scientific Conference, San Francisco, 19-22 October
2004
Hongbo, Y., Thomas, C. L., Harrison, M. A., SALEK, M. S. & Finlay, A. Y. (2004) Translating the science of quality of life into practice: what do DLQI scores mean? British Association of Dermatologists. Abstract Book. 6th - 9th July 2004.
SALEK. S, David. S., Ahmed. Z. & Finlay A. (2004) Evaluation of the relevance of HRQOL discussion in outpatient consultation to the level of impairment as measured by the DLQI. Quality of Life Research. 13(9). 1522.
SALEK S. (2004) The importance of being subjective. Good Clinical Practice Journal. 11(12). 25-27.
SALEK MS. (2004) Compendium of quality of life instruments. Quality of Life Newsletter. 33. 12-13.
David, S., SALEK, M.S., Ahmed, Z. and Finlay, A.Y. (2004) Health related quality of life discussion during dermatology outpatient consultations and its relationship with patient DLQI scores. WSP UG 2004 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 23.
Clark, W.J., McAuslane, J.A.N., SALEK, M.S. and Walker, S.R. (2004) Assessment of the regulatory changes in the regulatory environment on drug development and approval times. WSP UG 2004 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 20.
Chan, W.Y., SALEK, M.S. and Setter, S.M. (2004) Use of anticholinergics in community-dwelling homebound elderly dementia patients. WSP UG 2004 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 19.
Ahmed, Z., David, S., SALEK, M.S. & Finlay, A.Y. (2004) Is there a relationship between the DLQI score and quality of life related discussion in dermatology outpatient clinic consultations?. Journal of the European Academy of Dermatology and Venereology. 18(Suppl. 2). 537
Ali. T. and SALEK. M.S. (2004) Evaluation of the humanistic burden of dyskinesias in patients with Parkinson’s disease (PD). Quality of Life Research. 13(9). 1534.
SALEK. M.S. and David. S. (2004) Evaluation of the relevance of HRQoL discussion in outpatient consultation to the level of impairment as measured by the DLQI. Quality of Life Research. 13(9). 1522.
Lua. P.L., SALEK. M.S., Finlay. I.G., Boay, A.G.I. & Mohd. Said, R. (2004) Health-related quality of life in cancer population receiving different therapies in Sabah, Malaysia. Quality of Life Research. 13(9). 1600.
Lua. P.L., SALEK. M.S., Finlay. I.G., Boay, A.G.I. & Mohd. Said, R. (2004) Reliability, validity and feasibility of the Malay McGill Quality of Life Questionnaire (MMQOL) in Malaysian cancer population. Quality of Life Research. 13(9). 1518.
Ali. T., Lane. R. and SALEK. M.S. (2004) Convergent and discriminative validity of the UKSIP and SF-36 in patients with Parkinson’s disease (PD). Quality of Life Research. 13(9). 1533.
SALEK MS. (2004) Volume 6 - Compendium of Quality of Life Instruments Haslemere, Euromed Communications.
Hongbo, Y., Thomas, C.L., Harrison, M.A., SALEK, M.S. & Finlay, A.Y. (2004) Translating the science of quality of life into practice: what do Dermatology Life Quality Index (DLQI) scores mean? British Journal of Dermatology. 151 (suppl 68), 45-46.
Hongbo, Y., Thomas, C.L., Harrison, M.A., SALEK, S.S. and Finlay, A.Y. (2004) Banding of the Dermatology Life Quality Index (DLQI) total scores according to a global question in outpatients. IX International Congress of Dermatology, May 19-22, Beijing, China. Book of Abstracts. 229.
SALEK, M.S., Coombe, E.E. and Achey, L. (2004). Use of ACE inhibitors and aspirin in a family practice clinic: development of protocols to increase awareness and usage in patients with type 2 diabetes. Pharmacy World and Science. 26(2). A83.
SALEK, M.S., Sheehan, N. and Poole, C. (2004). Design and clinical utility testing of care pathway algorithms for electronic clinical decision support in Parkinson’s disease. Pharmacy World and Science. 26(2). A77.
SALEK, M.S., Gill, H.K., Clifton, D., Heaton, K. and Bayer, H. (2004). Assessment of patient satisfaction with telepharmacy. Pharmacy World and Science. 26(2). A55.
Sanghani, S., SALEK, M.S. and Kloft, C. (2004). Ethnographic and participant observation methods of testing the feasibility of undertaking a cross-cultural project in community pharmacy standards. Pharmacy World and Science. 26(2). A22.
SALEK, M.S., Dafydd, L. and Evans, S. (2004). Implementation of medicines management at an oncology centre. Pharmacy World and Science. 26(2). A20.
SALEK, M.S. and Reddin, M.I. (2004). The diabetes team: lifestyle, glucose monitoring and clinic care. Pharmacy World and Science. 26(2). A16.
SALEK, M.S., Harrison, M.A., Hongbo, Y. and Finlay, AY. (2004). Assessment of quality of life in patients with chronic disease: what does incremental change in scores mean? Pharmacy World and Science. 26(2). A10.
SALEK, M.S., Finlay, A.Y. Lewis, J.J. & Sumner, M.J. (2004). Quality of life improvement in treatment of psoriasis with intermittent short course Cyclosporin (Neoral®). Quality of Life Research. 13(1). 91-95.
2003
Finlay, I.G., Pratheepawanit, N. and SALEK, M.S. (2003) Monitoring self-reported quality-of-life among patients attending a palliative medicine outpatient clinic. Palliative Medicine. 17. 83-84.
Azzopardi, L.M., Serracino-Inglott, A., SALEK, S. and Zarb-Adami, M. (2003) Development of external methods to evaluate the quality of pharmacy services offered by community pharmacists. Quality Assurance Journal. 7. 248-257.
Lua, L.L., SALEK, M.S., Finlay, I.G., Boay, A.G.I. & Mohd Said, R. (2003) The reliability and validity of the Malay McGill Quality of Life Questionnaire - Cardiff Short Form (MMQOL-CSF) in Malaysian patients with advanced cancer. Quality of Life Research. 12(7). 818.
Lua, L.L., SALEK, M.S., Finlay, I.G., Boay, A.G.I. & Mohd Said, R. (2003) The feasibility and reliability of the Malay McGill Quality of Life Questionnaire - Cardiff Short Form (MMQOL-CSF) in Malaysian palliative care population. Quality of Life Research. 12(7). 819.
SALEK, M.S., Al-Mohammadi, A., Maughan, T., Mason, M. & Nicholls, P.J. (2003) Partnership in treatment decision-making and health-related quality of life in patients with cancer. Quality of Life Research. 12(7). 859.
Al-Mohammadi, A., SALEK, M.S., Maughan, T., Mason, M. & Nicholls, P.J. (2003) The impact of routine assessment of information needs on HRQoL of patients with cancer. Quality of Life Research. 12(7). 813.
Lua, P.L., SALEK, S., Finlay, I., Guat Im, A.B. & Said, R.M. (2003) Comparisons of health-related quality of life in Sabah cancer population receiving different treatment modalities. Journal of Business and Social Sciences, 9, 21-43.
Hongbo, Y., Harrison, M.A., SALEK, M.S. & Finlay, A.Y. (2003) What do the Dermatology Life Quality Index (DLQI) scores really mean in terms of patients’ overall quality of life. Quality of Life Research. 12(7). 778.
Azzopardi, L.M., Hudson, S.A., SALEK, M.S., Serracino-Inglott, A. & Zarb-Adami, M. (2003) MCQs in Pharmacy Practice. London, Pharmaceutical Press.
Hongbo, Y., Harrison, M.A., SALEK, M.S. & Finlay, A.Y. (2003) Assessing the meaningfulness of Dermatology Life Quality Index scores. Journal of the European Academy of Dermatology and Venereology. 17 (Suppl 3). 113.
Van den Haak, M.A., SALEK, S. and Walker, S.R. (2003) Drug development failures: what can be learnt from them? 39th Annual DIA Meeting, June 15-19, 2003. Henry B. Gonzalez Convention Center, San Antonio, TX, USA.
Reddin, M.I. & SALEK, M.S. (2003) The diabetes team: lifestyle, glucose monitoring and clinic care. WSP UG 2003 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 65.
Harrison, M.A., SALEK, M.S., Hongbo, Y. & Finlay, A.Y. (2003) Assessing the meaningfulness of Dermatology Life Quality Index (DLQI) scores. WSP UG 2003 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 29.
Dafydd, L., SALEK, M.S. & Evans, S. (2003) Implementation of medicines management at an oncology centre. WSP UG 2003 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 15.
Coumbe, E. E., SALEK, M.S. & Achey, L. (2003) Use of ACE inhibitors and aspirin in a family practice clinic in the United States: development of protocols to increase awareness and usage in patients with type 2 diabetes. WSP UG 2003 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 13.
Al-Mohammadi, A., SALEK, M.S., Maughan, T., Nicholls, P. & Mason, M. (2003) The impact of routine assessment of information needs on patient outcomes. Psycho Oncology. 12. 641.
SALEK, M.S., Millar, B., Darby, E., Turpin, S., Coles, G.A. & Maggs, C. (2003) Health related quality of life of home dialysis patients and their carers. Journal of Applied Therapeutic Research. 4(2). 11-18.
Serracino-Inglott, A., Zarb-Adami, M., Azzopardi, L.M., SALEK, M.S., Camilleri, A. (2003) Monitoring the prevalence and treatment cost of pressure sores in a geriatric hospital. Journal of the European Academy of Dermatology and Venereology. 17(suppl 1), 60-61.
Azzopardi, L.M., Serracino-Inglott, A., Zarb-Adami, M., SALEK, M.S., Mifsud, S. (2003) Responding to skin problems. Journal of the European Academy of Dermatology and Venereology. 17(suppl 1), 56-57.
Azzopardi, L.M., Serracino-Inglott, A., Zarb-Adami, M., SALEK, M.S., Galea, L. (2003) Quality of life assessment in patients with acne. Abstract Book. ESCP 4th Spring Conference on Clinical Pharmacy. 10.
Finlay, A.Y., SALEK, M.S. & Haney, J. (2003). Intramuscular alefacept improves health-related quality of life in patients with chronic plaque psoriasis. Dermatology. 206(4). 307-315.
SALEK, M.S. & Finlay, A.Y. (2003) Quality of life in patients with severe psoriasis receiving cyclosporin: a multicentre study. Journal of Applied Therapeutic Research. 4(1): 3-10.
2002
Van den Haak, M.A., SALEK, S. and Walker, S. (2002) New product launches: what will the future bring? 38th Annual DIA Meeting, June 16-20, 2002. The New Lakeside Center at McCormick Place, Chicago, IL, USA.
Anderson, C., SALEK, S., Walker, S.R. & McAuslane, J.A.N. (2002) Acceptance of Foreign Clinical Data in the ICH regions - the ICH E5 Guideline. Welsh School of Pharmacy, Cardiff University CMR International Institute for Regulatory Science Annual DIA Chicago 2002
Matthews, E., SALEK, M.S., St Dennis, C. & Ellington, J.E. (2002) Parenteral haloperidol as a chemical restraint: assessment of use, development of a staff educational module and treatment protocols for a hospital in the USA. WSP UG 2002 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 55.
Gill, H. K., SALEK, M.S., Heaton, K., Byer, H. & Clifton, D. (2002) The development and application of a patient satisfaction survey for the telepharmacy and pharmaceutical care services at an ambulatory pharmacy. WSP UG 2002 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 29.
English, S., SALEK, M.S., McAuslane, N., Walker, S.R & Luscombe, D.K. (2002) Is the regulatory environment changing for the submission and approval of new active substances. WSP UG 2002 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 23.
Basford, A., SALEK, M.S. & Singer, B. (2002) Evaluation of polypharmacy in an inpatient psychiatric hospital. WSP UG 2002 Research Project Abstracts. (ed. John, D.N.). STS Publishing: Cardiff. 5.
Mussen, F., SALEK, M.S. & Walker, S. (2002) What is the best model for assessing the benefit/risk ratio for my product? In VandenBerg, M., SALEK, S. & Wight, L. Dilemmas and Solutions in Global Drug Development. Your Questions Answered. PJB Publications Ltd.
SALEK, M.S. (2002) How do I go about constructing and validating my own index and including quality of life measures in my clinical studies, taking into account the choice between general and disease specific instruments and cross cultural issues? In VandenBerg, M., SALEK, S. & Wight, L. Dilemmas and Solutions in Global Drug Development. Your Questions Answered. PJB Publications Ltd.
VandenBerg, M., SALEK, S. & Wight, L. (2002) Dilemmas and Solutions in Global Drug Development. Your Questions Answered. PJB Publications Ltd.
Evans, N., Poole, C., SALEK, S., Siebert, S., Evans, J. & Hunt, J. (2002) Depression in people with Parkinson’s disease. Welsh Primary Care Research and Clinical Effectiveness Symposium Abstract Book. 5th December. 4.
Poole, C., Bater, T., SALEK, S., Sastry, D., Morgan, L., Raha, S & Bayer, T. (2002) The Welsh Movement Disorder eNetwork: technology recycling for a cost-effective management solution in specialist clinical settings. Welsh Primary Care Research and Clinical Effectiveness Symposium Abstract Book. 4th December. 5.
Al-Mohammadi, A., SALEK, M.S., Maughan, T., Nicholls, P. & Mason, M. (2002) The impact of routine assessment of information needs on patient outcomes. Abstract Book 19th Annual Conference of the British Psychosocial Oncology Society. 4th - 6th December 2002. 9.
Edgar, A. & SALEK, S. (2002) Fancy a bite? A look at the ethics involved in marketing mousetraps and pharmaceuticals. Pharmaceutical Marketing. 1st November. 24-25.
SALEK, M.S., Woods, F. & Adams, A. (2002) Medicines information helpline for patients with Parkinson’s disease. UK Medicines Information Conference. Chester 19-21st September 2002.
Lua, P.L., SALEK, M.S., Finlay, I.G. and Pratheepawanit, N. (2002) The reliability of McGill quality of life questionnaire - Cardiff Short Form (MQOL-CSF) in palliative care. Quality of Life Research. 11(7): 650.
Lua, P.L., SALEK, M.S., Finlay, I.G. and Pratheepawanit, N. (2002) Feasibility, reliability and validity of McGill quality of life questionnaire - Cardiff Short Form (MQOL-CSF) in palliative care. Quality of Life Research. 11(7): 650.
SALEK, S. & Pratheepwannit, N. (2002) Impact of erythrpoietin on HRQOL of predialysis chronic renal failure patients: a longitudinal study. Quality of Life Research. 11(7): 674.
Ali, T. and SALEK, S. (2002) Comparison of the PDQ-39 with a generic measure of health status (UK Sickness Impact Profile) in Parkinson’s disease subjects. Quality of Life Research. 11(7): 672.
Ali, T. and SALEK, S. (2002) Reliability of the PDQ-39 and a generic measure of health status (UK Sickness Impact Profile) in Parkinson’s disease. Quality of Life Research. 11(7): 671.
SALEK, M.S., Basford, A. & Singer B. (2002) Evaluation of polypharmacy in an inpatient psychiatric hospital. Abstract Book. ESCP 31st European Symposium on Clinical Pharmacy. Florence, Italy. 59.
SALEK, M.S., Matthews, E.S., St Dennis, C., Sodorff, M. & Pickette, S. (2002) Evaluation of the use of parenteral haloperidol as a chemical restraint. Abstract Book. ESCP 31st European Symposium on Clinical Pharmacy. Florence, Italy. 59.
SALEK, M.S., English, S.E., McAuslane, N., Anderson, C. & Luscombe, D.K. (2002) The impact of recent increase in withdrawals on the regulatory approval of new drugs. Abstract Book. ESCP 31st European Symposium on Clinical Pharmacy. Florence, Italy. 59.
Lua, PL., SALEK, M.S., Pratheepawanit, N. & Finlay, I.G. (2002) Pharmaceutical care in advanced cancer: using patients’ baseline quality of life information as a guide for treatment decision making. Pharmacy World & Science. 24(1): 36.
SALEK. M.S., Rogers, M., Evans, N. & Luscombe, D.K. (2002) Study to assess knowledge of medications in people with Parkinson’s disease. Pharmacy World & Science. 24(1): 33.
SALEK, M.S., Sach, M., Rowe, N., Evans, N. & Luscombe, D.K. (2002) The prevalence of drug treatments for depression and dementia in people with Parkinson’s disease. Pharmacy World & Science. 24(1): 28.
SALEK, M.S., Rowe, N., Sach, M., Evans, N. & Luscombe, D.K. (2002) Drug profiling and assessment of quality of life in Parkinson’s disease patients. Pharmacy World & Science. 24(1): 25.
SALEK, M.S. (2002) Holistic approach in choice of pharmaceutical agents: ethical responsibilities. In SALEK, S. & Edgar, A. Pharmaceutical Ethics. Chichester, John Wiley & Sons.
SALEK, S. & Edgar, A. (2002) Pharmaceutical Ethics. Chichester, John Wiley & Sons.
Walker, M.D. & SALEK S. (2002) Quality of life assessment in dementia research. In Gauthier, S. & Cummings, J.L. (eds.) Alzheimer’s Disease and Related Disorders Annual 2002. London: Taylor Dunitz. 113-146.
Walker, M.D. & SALEK, S. (2002) The Community Dementia Quality of Life Profile (CDQLP): a newly developed health-related quality of life (HRQOL) measure suitable for use in clinical trials. Abstract Book, Drug Information Association, 38th Annual Meeting. 53.
Van den Haak, M., SALEK, S. & Walker, S. (2002) Recent trends in new product launches, 1996-2001. Abstract Book, Drug Information Association, 38th Annual Meeting. 53.
English, S., Anderson, C.A., SALEK, M.S. & McAuslane, A.N. (2002) Is the regulatory environment changing for the approval of new active substances (NASs)? Abstract Book, Drug Information Association, 38th Annual Meeting. 47.
Anderson, C., SALEK, S. & Walker, S. (2002) Acceptance of foreign clinical data in ICH regions: the E5 guideline. Abstract Book, Drug Information Association, 38th Annual Meeting. 46.
Zarb Adami, M., Azzopardi, L.M., Serracino Inglott, A. & SALEK, S. (2002) Clinical pharmacy research skills in undergraduate pharmacy curriculum. Abstract Book. ESCP 3rd Spring Conference on Clinical Pharmacy. 29-A.
Zarb Adami, M., Serracino Inglott, A., Azzopardi, L.M., SALEK, S. & Gabaretta, M. (2002) Dissemination of information on contact lens care. Abstract Book. ESCP 3rd Spring Conference on Clinical Pharmacy. 28-A.
Azzopardi, L.M., Serracino Inglott, A., Zarb Adami, M., SALEK, S. & Vella, I. (2002) Pharmacists’ advice on preconception and prenatal care. Abstract Book. ESCP 3rd Spring Conference on Clinical Pharmacy. 20-A.
Serracino Inglott, A., Zarb Adami, M., Azzopardi, L.M., SALEK, S. & Caruana, S. (2002) Management of helicobacter pylori infection. Abstract Book. ESCP 3rd Spring Conference on Clinical Pharmacy. 18-A.
Azzopardi, L.M., Serracino Inglott, A., Zarb Adami, M., SALEK, S. & Mifsud, S. (2002) Pharmacist intervention in responding to skin problems. Abstract Book. ESCP 3rd Spring Conference on Clinical Pharmacy. 11-A.
SALEK, S., Pratheepawanit, N., Finlay, I., Luscombe, D. (2002) The use of quality-of-life instruments in palliative care. European Journal of Palliative Care. 9(2): 52-56
2001
Luscombe, D.K. and SALEK, M.S. (2001) An International Postgraduate Course in Pharmaceutical Medicine: a 25-year review. International Journal of Pharmaceutical Medicine. 15: 261-263.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (2001) Impact of health-related quality of life outcomes on clinical decision making in practice. Abstract Book. Research and Development Conference, Primary Care Symposium. 27.
Walker, M.D., SALEK, M.S. & Bayer, A.J. (2001) Quality of life in community practice: assessing patients needs in dementia. Abstract Book. Research and Development Conference, Primary Care Symposium. 22.
Walker, M.D., SALEK, M.S. & Bayer, A.J. (2001) The reliability of the Community Dementia Quality of Life Profile (CDQLP). Abstract Book. Research and Development Conference, Primary Care Symposium. 22.
Anderson, C., SALEK, S. & Walker, S.R. (2001) Review times - is there still room for improvement? Welsh School of Pharmacy, Cardiff University CMR International Institute for Regulatory Science, Annual DIA Denver 2001.
Pratheepawanit, N., SALEK, M.S., Finlay, I.G. Luscombe D.K. (2001) What could pharmacy practitioners do for palliative care services? Abstract Book. Research and Development Conference, Primary Care Symposium. 20.
Walker, M.D., SALEK, M.S. & Bayer, A.J. (2001) The relationship between the quality of life (QOL) of dementia patients and their carers: validation of the Community Dementia Quality of Life Profile (CDQLP). Abstract Book. Research and Development Conference, Primary Care Symposium. 15.
Walker, M.D., SALEK, M.S. & Bayer, A.J. (2001) Comparison of two disease-specific quality of life (QOL) measures: validation of the Community Dementia Quality of Life Profile (CDQLP). Quality of Life Research. 10(3): 260.
Walker, M.D., SALEK, M.S. & Bayer, A.J. (2001) Validation of the Community Dementia Quality of Life Profile (CDQLP): comparison with the EUROQOL-5D (EQ-5D). Quality of Life Research. 10(3): 260.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. Evaluation of a novel pain management programme and its impact on quality of life. Quality of Life Research. 10(3): 248.
Lua, P.L., SALEK, M.S., Pratheepawanit, N. & Finlay, I.G. (2001) Does health-related quality of life assessment in routine practice improve patient outcomes? Quality of Life Research. 10(3): 244.
Pratheepawanit, N., SALEK, M.S., Lua P.L. & Finlay, I.G. (2001) Development of the Short Form McGill Quality of Life Questionnaire. Quality of Life Research. 10(3): 212
SALEK, M.S. & Pratheepawanit, N. (2001) Use of erythropoietin in early anaemia improves HRQOL in predialysis chronic renal failure patients. Quality of Life Research. 10(3): 198.
Evans, N. & SALEK, M.S. (2001) Parkinson’s disease: treatment choices. Chemist & Druggist. 4th August. I-VI.
Azzopardi, L.M., SALEK, M.S., Serracino-Inglott, A., Zarb Adami, M. & Buhagiar, A. (2001) Validating tools for the monitoring of community pharmacy services. The Pharmaceutical Journal. 267: 303-305
SALEK, M.S. (2001) Pharmacists frustrated by responsibility without authority. The Pharmaceutical Journal. 266: 692.
Lua, P.L., SALEK, M.S., Pratheepawanit, N. & Finlay, I.G. (2001) Pharmaceutical care in advanced cancer: using patients’ baseline quality of life information as a guide for treatment decision making. Abstract Book. ESCP 30th European Symposium on Clinical Pharmacy. 10-13 October. 24-A.
SALEK, M.S., Sach, M., Rowe, N., Evans, N. & Luscombe, D.K. (2001) The prevalence of drug treatments for depression and dementia in people with Parkinson’s disease. Abstract Book. ESCP 30th European Symposium on Clinical Pharmacy. 10-13 October. 3-A.
SALEK, M.S., Rowe, N., Sach, M., Evans, N. & Luscombe, D.K. (2001) Drug profiling and assessment of quality of life in Parkinson’s disease patients. Abstract Book. ESCP 30th European Symposium on Clinical Pharmacy. 10-13 October. 7-A.
SALEK, M.S., Rogers, M., Ahmadi, M., Evans, N. & Luscombe, D.K. (2001) A study to assess knowledge of medications in people with Parkinson’s disease. Abstract Book. ESCP 30th European Symposium on Clinical Pharmacy. 10-13 October. 13-A.
Al-Mohammadi, A., SALEK, M.S., Nicholls, P.J. & Mason, M. (2001) Oncologists perceptions of cancer patients and their information needs. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 22-A.
Walker, M.D., SALEK, M.S. & Bayer, A. (2001) Quality of life in community practice: assessing patient needs in dementia. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 15-A.
Azzopardi, L.M., Serracino-Inglott, A., Zard Adami, M. & SALEK, M.S. (2001) Awareness of nutritional needs amongst pre- and post-conception women. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 16-A.
Azzopardi, L.M., SALEK M.S., Serracino-Inglott, A. & Zard Adami, M. (2001) Validation of community pharmacists intervention in responding to patients’ needs for treatment of minor illnesses. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 16-A.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (2001) Impact of chronic pain management on patients’ quality of life: comparison of two systems. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 22-A.
Serracino-Inglott, A., Zard Adami, M., Azzopardi, L.M. & SALEK, M.S. (2001) Pharmacy practice teaching: does it influence practice competency of the new graduates? Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 7-A.
Al-Theyab, A.A., SALEK, M.S. & Nicholls, P.J. (2001) Patient perspectives of pharmaceutical services. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 2-A.
Al-Hazmi, Y., SALEK, M.S., Nicholls, P.J. (2001) Prevalence of antibiotic misuse and its implications. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 2-A.
Al-Mohammadi, A., SALEK, M.S., Nicholls, P.J. & Mason, M. (2001) Medical information in oncology: assessments of patients needs and outcomes. Abstract Book. ESCP 2nd Spring Conference on Clinical Pharmacy. 2-5 May, Malta. 2-A.
Walker, M.D., SALEK, S. & Bayer, A.J. (2001) The relationship between the quality of life (QoL) of dementia patients and their carers: validation of the Community Dementia Quality of Life Profile (CDQLP). Age & Ageing, 30 (Suppl 2), 62.
Walker, M.D., SALEK, S. & Bayer, A.J. (2001) Assessing patient and carer quality of life (QoL) in dementia: validating the concept of a composite measure. Age & Ageing, 30 (Suppl 2), 61.
2000
Serracino Inglott, A., Zarb Adami, M., Azzopardi, L. M. & SALEK, S. (2000) Teaching semiotics to pharmacy students. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 118.
Serracino Inglott, A., Azzopardi, L. M., Zarb Adami, M. & SALEK, S. (2000) Experiential learning of pharmacy practice. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 118.
Zarb Adami, M., Serracino Inglott, A., Azzopardi, L. M. & SALEK, S. (2000) Pharmacy teaching staff and students perception of the internet. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 108.
Serracino Inglott, A., Azzopardi, L. M., Zarb Adami, M. & SALEK, S. (2000) Occurrence and treatment of otomycosis in a holiday resort. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 76.
Azzopardi, L. M., Serracino Inglott, A., Zarb Adami, M., Vella, I. & SALEK, S. (2000) Nutrition amongst pre- and post-conception women. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 76.
Azzopardi, L. M., Serracino Inglott, A., Zarb Adami, M., Caruana, S. & SALEK, S. (2000) Preventative dental health care. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 76.
Zarb Adami, M., Serracino Inglott, A., Azzopardi, L. M., Demanjo, D. M. & SALEK, S. (2000) Responding to symptoms of dental infections. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 75.
Azzopardi, L. M., SALEK, S., Serracino Inglott, A. & Zarb Adami, M. (2000) Responding to symptoms of dental infections. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 74.
Zarb Adami, M., Serracino Inglott, A., Azzopardi, L. M., Micallef, J. J. & SALEK, S. (2000) Pharmacist intervention in educating diabetics with risk of renal failure. Book of Abstracts. 60th International Congress of FIP. Pharmacy World Congress 2000. 68.
Azzopardi, L. M., Serracino Inglott, A., Zarb Adami, M., SALEK, S. & Mifsud, S. (2000) Pharmacists’ intervention improves management of skin conditions. Pharmacy World & Science. 22(5/6), A9.
Serracino Inglott, A., Zarb Adami, M., Azzopardi, L. M., SALEK, S. & Camilleri, A. (2000) Monitoring the prevalence and treatment cost of pressure sores by pharmacists in a geriatric hospital. Pharmacy World & Science. 22(5/6), A24.
Zarb Adami, M., SALEK, S., Serracino Inglott, A. & Azzopardi, L. M. (2000) Perception of cost of medicines by the public. Pharmacy World & Science. 22(5/6) A22.
Azzopardi, L. M., SALEK, S., Serracino Inglott, A. & Zarb Adami, M. (2000) Reliability testing of a patient satisfaction questionnaire for patients discharged from an acute geriatric hospital. Pharmacy World & Science. 22(5/6), A22.
Evans, N.A., SALEK, M.S., Jones, S.W., Hood, K. & Sastry, D. (2000) Assessment of patient knowledge of their medications in an outpatient Parkinson’s disease clinic. Pharmacy World & Science. 22(5/6), A6.
Al-Mohammadi, A., SALEK. S., Nicholls, P. J. & Mason M. (2000) Assessment of the patient’s perspective of information needs by pharmacists. Pharmacy World & Science. 22(5/6), A24.
Walker, M.D., SALEK, S. & Bayer, A. (2000) The reliability of the Community Dementia Quality of Life Profile (CDQLP). Quality of Life Research. 9(3) 329.
Ozsogut, B., Karabulut, E., SALEK, S. & Demirdamar, R. (2000) Development of the Turkish Sickness Impact Profile (TR - SIP) - validity. Quality of Life Research. 9(3) 332.
Ozsogut, B., Karabulut, E., SALEK, S. & Demirdamar, R. (2000) Development of the Turkish Sickness Impact Profile (TR - SIP) - reliability. Quality of Life Research. 9(3) 315.
Ozsogut, B., Karabulut, E., SALEK, S. & Demirdamar, R. (2000) Development of the Turkish Sickness Impact Profile (TR - SIP) - applicability and practicality. Quality of Life Research. 9(3) 315.
Azzopardi, L. M., SALEK, S., Serracino Inglott, A. & Zard Adami, M. (2000) Participation of medical doctors in professional auditing systems: validation of community pharmacy. Book of Abstracts. 6th Mediterranean Medical Congress and the 2nd Mediterranean Summer School Focus on Hypertension, Diabetes and Hyperlipidaemia. 212.
Azzopardi, L.M., SALEK, S., Serracino Inglott, A. & Zarb Adami, M. (2000) Practical guidelines to conduct a validation study. In Azzopardi L.M. (ed.) Validation Instruments for Community Pharmacy. Pharmaceutical Care for the Third Millennium. New York, Pharmaceutical Products Press. 149-186.
SALEK, S. & Serracino Inglott, A. (2000) The concepts of pharmacy practice leading to the development of validation instruments. In Azzopardi L.M. (ed.) Validation Instruments for Community Pharmacy. Pharmaceutical Care for the Third Millennium. New York, Pharmaceutical Products Press. 1-12.
SALEK, S. (2000) The effectiveness of routine quality of life information on doctors’ behaviour in palliative care outpatient consultations. Journal of Oncology Pharmacy Practice, 6(1), 19.
SALEK, S. (2000) Quality of life: emerging aspects of oncological care. Journal of Oncology Pharmacy Practice, 6(1), 17.
Zarb Adami, M., SALEK, M.S., Serracino Inglott, A. & Azzopardi, L.M. (2000) Patient views on the cost value of side effect reduction. Proceedings of European Society for Clinical Pharmacy Spring Conference on Clinical Pharmacy: Clinical Pharmacy for the New Therapeutic Horizons. Reykjavik, Iceland. 018. 6-A.
Azzopardi, L.M., SALEK, M.S., Serracino Inglott, A. & Zarb Adami, M. (2000) Evaluation of professional pharmacy services in the community setting. Proceedings of European Society for Clinical Pharmacy Spring Conference on Clinical Pharmacy: Clinical Pharmacy for the New Therapeutic Horizons. Reykjavik, Iceland. 021. 2-A.
Azzopardi, L.M., SALEK, M.S., Serracino Inglott, A. & Zarb Adami, M. (2000) An insight into the Validation of Community Pharmacy Method. Pharmacy World & Science, 22(1), A23-24.
SALEK, M.S., Evans, N.A., Poole, S.M., Bayer, A.J. & Luscombe, D.K. (2000) Quality of life of carers of patients with Parkinson’s disease and Alzheimer’s disease - are they different? Pharmacy World & Science, 22(1), A12.
SALEK, M.S., Sharp, J.K., Bayer, A.J., Walker, M.D. & Luscombe, D.K. (2000) Quality of life measurement in Alzheimer’s patients and their carers: a comparison between statutory and non-statutory care service. Pharmacy World & Science, 22(1), A12.
SALEK, M.S., Poole, S.M., Evans, N.A., Bayer, A.J. & Luscombe, D.K. (2000) Health-related quality of life assessment in patients with Parkinson’s disease and their carers. Pharmacy World & Science, 22(1), A30.
Pratheepawanit, N., SALEK, M.S., Finlay, I.G. & Luscombe, D.K. (2000) What could pharmacy practitioners do for palliative care services? Pharmacy World & Science, 22(1), A30.
SALEK, M.S., Pratheepawanit, N. & Finlay I.G. (2000) Use of quality of life outcomes in routine assessment of patients with cancer: breaking the barriers. Oncology Economics, 1(3), 42-46.
1999
SALEK, M.S., Walker, M.D. & Bayer, A.J. (1999) A review of quality of life in Alzheimer’s disease. Parts 1 and 2: Issues in assessing disease impact and drug effects. Correspondence. Pharmacoeconomics, 16(4), 417-419.
Azzopardi, L.M., SALEK, M.S., Serracino Inglott, A. & Zarb Adami, M. (1999) A validation method to document the value of the community pharmacist when responding to symptoms. ACCP-ESCP International Congress on Clinical Pharmacy, Orlando, Florida, 11-14 April, 363.
Pratheepawanit, N., SALEK, M.S., Finlay, I.G. & Luscombe D.K. (1999) Quality of life as a new outcome measure in clinical practice. Value in Health, 2(5), 504.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (1999) Health-related quality of life assessment in practice. Quality of Life Research, 8(7), 644.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (1999). Impact of health-related quality of life outcomes on clinical decision making in practice. Quality of Life Research, 8(7), 644.
SALEK, S.M., Walker, M.D. & Bayer, A.J. (1999) The community dementia quality of life profile (CDQLP): a factor analysis. Quality of Life Research, 8(7), 660.
Ozsogut, B., SALEK, M.S. & Demirdamar, R. (1999) Development of the Turkish sickness impact profile (TR-SIP) - weighting scores. Quality of Life Research, 8(7), 660.
Jakkai, E.A., SALEK, M.S., Hasan & M.Y. (1999). The Arabic Sickness Impact Profile: content validation, severity ratings and weighting scores. Quality of Life Research 8(7), 661.
Jakkai, E.A., SALEK, M.S. & Hasan, M.Y. (1999) Development of the Arabic Sickness Impact Profile (A-SIP) - translation phase. Quality of Life Research, 8(7), 661.
Azzopardi, L.M., SALEK, M.S., Serracino Inglott, A. & Zarb Adami, M. (1999) An innovative auditing system: validation of community pharmacy. The Pharmaceutical Journal. 263(7063), R264.
Ozsogut, B., SALEK, M.S. and Demirdamar, R. (1999) Content validation of the Turkish adaptation of a general quality of life instrument (UK-SIP): a novel technique for pharmacotherapeutics outcomes assessment. The Pharmaceutical Journal, 263(7063), R24.
SALEK, M.S., Walker M.D. & Bayer A. J. (1999) A review of quality of life in Alzheimer’s disease. Parts 1 and 2: issues in assessing disease impact and drug effects. Correspondence. Pharmacoeconomics; 15(6), 641-644.
SALEK, M.S. (1999) The ethics of health economics. Pharmaceutical Physician. 10(1), 20-21.
Azzopardi, L.M., SALEK, M.S., Serracino Inglott, A. & Zard Adami, M. (1999) An insight into the validation of community pharmacy method. Pharmacy World & Science, 22(1), A23.
Pritchard, C., SALEK, M.S. & Cohen, D. (1999) Economic evaluation of Granulocyte macrophage colony stimulating factor in patients with small cell lung cancer. 4th Congress of the European Association of Hospital Pharmacists. Nice, France, 17-19 March, 29.
Pratheepawanit, N., SALEK, M.S. & Finlay, I.G. (1999) Pharmacist’s role in terminal care: lesson learned from routine assessment of patients’ perception. 4th Congress of the European Association of Hospital Pharmacists. Nice, France, 17-19 March, 24.
SALEK, M.S. & Van der Kuy, A. (1999) Pharmacoeconomics: practical application. 4th Congress of the European Association of Hospital Pharmacists. Nice, France, 17-19 March, 22.
Azzopardi, L.M., SALEK, S., Serracino Inglott, A. & Zarb Adami, M. (1999) Community pharmacy validation tools: from basics to provision of pharmaceutical care. Pharmaceutical Care Network Europe. International Conference on Outcome Measurements in Pharmaceutical Care. Hillerod, Denmark, 26-29 January, 1.
Azzopardi, L.M., SALEK, S., Serracino Inglott, A. & Zarb Adami, M. (1999) Quantifying professional pharmacy services within the method of validation of community pharmacy. FIP ’99. Barcelona, 5-10 September, 119.
Azzopardi, L.M., SALEK, S., Serracino Inglott, A. & Zarb Adami, M. (1999) Measuring the contribution of the community pharmacist: validation of community pharmacy. Journal of the American Pharmaceutical Association, 39 (2), 261.
Prataheepawanit, N., SALEK, M.S. & Finlay, I.G. (1999) The applicability of quality of life assessment in palliative care: comparing two quality of life measures. Palliative Medicine, 13, 325-334.
SALEK, M.S. (1999). Quality of life in patients with end-stage renal disease. Journal of Applied Therapeutic Research, 2 (3), 163-170.
SALEK MS, Editor. (1999) Pharmacoeconomics and Outcome Assessment - A Global Issue. Hasslemere, Euromed Communications.
1998
Abahussain, E., Hasan, F.A.M., Nicholls, P.J. & SALEK, S. (1998) Do the referring physicians in Kuwait accept the role of helicobacter pylori in peptic ulcer diseases. Gulf health development: a shared goal. The First Arabian Gulf Medical Associations Conference. 24-26 November, Bahrain, 105.
SALEK MS. (1998) Volume 5 - Compendium of Quality of Life Instruments Chichester, John Wiley & Sons.
SALEK MS. (1998) Volume 4 - Compendium of Quality of Life Instruments Chichester, John Wiley & Sons.
SALEK MS. (1998) Volume 3 - Compendium of Quality of Life Instruments Chichester, John Wiley & Sons.
SALEK MS. (1998) Volume 2 - Compendium of Quality of Life Instruments Chichester, John Wiley & Sons.
SALEK MS. (1998) Volume 1 - Compendium of Quality of Life Instruments Chichester, John Wiley & Sons.
Edgar A, SALEK S, Shickle D & Cohen D. (1998) The Ethical QALY: Ethical Issues in Healthcare Resource Allocations. Hasslemere, Euromed Communications.
Prataheepawanit, N., SALEK, M.S., Luscombe, D.K. & Finlay, I.G. (1998) Quality of life assessment in palliative care. Proceedings of the ESCP 27th European Symposium on Clinical Pharmacy, Jerusaelm, Israel, October 26-29.
Pratheepawanit, N., SALEK, M.S., Finlay, I.S. & Luscombe, D.K. (1998) Routine assessment of quality of life in patients receiving palliative care and its value in clinical decision making. Quality of Life Research, 7 (7), 652.
Ozsogut, B., SALEK, M.S. & Demirdamar, R. (1998) Development of the Turkish Sickness Impact Profile (TRSIP) - translation phase. Quality of Life Research, 7 (7), 646-647.
Chairojkanjana, K., SALEK, M.S. & Prior, L. (1998) Attitudes about patient medication records in Thailand. In Progress in Clinical Pharmacy. Future Therapies and Clinical Pharmacy. Husson M.C., Batel Marques F.J. & Luscombe D.K. (eds). The Netherlands: European Society of Clinical Pharmacy. 336-344. ISBN 90-74383-17-3.
Azzopardi LM, Serracino Inglott A, SALEK, M.S., & Zarb Adami M. (1998) Pharmacist’s intervention during chemotherapy treatment greatly reduces side effects in patients with breast cancer: a validation study. In Progress in Clinical Pharmacy. Future Therapies and Clinical Pharmacy. Husson M.C., Batel Marques F.J. & Luscombe D.K. (eds). The Netherlands: European Society of Clinical Pharmacy. 150-152. ISBN 90-74383-17-3.
Chairojkanjanna, K., SALEK, M.S. & Prior, L. (1998) Public, patient and health professionals perceptions of community pharmacists and their role in the provision of patient medication records (PMRs). Thai FDA Journal, 1-3/2541, 7-21.
SALEK, M.S., Walker, M.D. & Bayer, A.J. (1998) A review of quality of life in Alzheimer’s disease. Part II: issues in assessing drug effects. PharmacoEconomics, 14 (6), 613-627.
Walker, M.D., SALEK, M.S. & Bayer, A.J. (1998) A review of quality of life in Alzheimer’s disease. Part I: issues in assessing disease impact. PharmacoEconomics, 14 (5), 499-530.
Walker, M.D., Bayer, A.J. & SALEK, M.S. (1998) Dementia - Quality of life and its measurement. Signpost, 3 (2), 4-6.
Azzopardi, L.M., SALEK, S., Serracino, A.I. and Adami, M.Z. (1998) Using community pharmacy validation tools to improve patient outcomes. FIP '98 Abstracts. Pharmacy World Congress '98. 58th International Congress of FIP. The Hague: The Netherlands. CPS-0-006.
Van der Kuy, A. and SALEK, S. (1998) Basic principles of pharmacoeconomics and quality of life measures in pharmacoeconomics. Proceedings of the 3rd Congress of the European Association of Hospital Pharmacists. Edinburgh, Scotland, UK. 23.
Pratheepawanit, N., SALEK, S., Luscombe, D.K. and Finlay, I.G. (1998) Quality of life in terminal care: is it relevant? The Pharmaceutical Journal, 261 (7012), R52.
Azzopardi, L.M., SALEK, S., Serracino, A.I. and Adami, M.Z. (1998) Development of external validation tools for community pharmacy. The Pharmaceutical Journal, 261 (7012), R49.
Azzopardi, L.M., SALEK, S., Serracino, A.I. and Adami, M. (1998) Validation of community pharmacy. Confirming the effectiveness of a pharmacist in a community setting. Journal of Euromed Pharmacy, 1 (4), 15-17.
Almuzaini, A.S., SALEK, M.S., Nicholls, P.J. & Alomar, B.A. (1998) The attitude of health care professionals toward the availability of hospice services for cancer patients and their carers in Saudi Arabia. Palliative Medicine, 12 (5), 365-373.
Azzopardi, L.M. & SALEK, S. (1998) Handbook of Methods for Community Pharmacy - Confirming the Effectiveness of the Pharmacist in a Community Setting. University of Malta.
Azzopardi, L.M., Serracino Inglott, A., SALEK, M.S., & Zarb Adami, M. (1998) Psychometric evaluation of validation tools for community pharmacy. Die Pharmazie, 53 (3), 1.
SALEK, M.S. (1998) Health related quality of life measurement in community pharmacy as part of pharmaceutical care delivery - is it relevant? In Pharmacy Symposium Project Reports. Serracino Inglott, A. (ed). Malta, Department of Pharmacy. 1-2.
1997
SALEK, M.S. (1997) Measuring the quality of life of patients with arthritis: validation and clinical applications of a self-administered health status instrument (UKSIP). Journal of Applied Therapeutics, 1 (3), 205-222.
Tremlett, H.L., SALEK, M.S., Wiles, C.M. and Luscombe, D.K. (1997) Health-related quality of life of multiple sclerosis patients and their carers. Pharmaceutical Journal, 259 (6968), R33.
SALEK, M.S., Finlay, A.Y. & Sumner, M.J. (1997) Quality of life impact of long-term cyclosporin in severe adult atopic dermatitis - An open multicentre study. Australasian Journal of Dermatology, 38 (2), 240.
SALEK, M.S., Finlay, A.Y. & Sumner, M.J. (1997) Intermittent short course cyclosporin (Neoral®) improves quality of life (QoL) in psoriasis. Australasian Journal of Dermatology, 38 (2), 108-109.
Price, M.J., SALEK, M.S., Davies, B.H., Walker, S.R., & Luscombe, D.K. (1997) Evaluation of the Sickness Impact Profile and Short Form-36 as measures of quality of life in asthma. Journal of Applied Therapeutics, 1 (3), 230-239.
SALEK S. (1997) Community pharmacy and health-related quality of life measurement - a challenging role. Thai FDA Journal, 4 (1) 7-17.
Almuzaini, A.S., SALEK, M.S., Alomar, B.A. & Nicholls, P.J. (1997) Present state of cancer care in Saudi Arabia: is there a need for provision of palliative care services? In Progress in Clinical Pharmacy - Optimising the Pharmacotherapy Process. Luscombe DK, Husson MC & Caramona M (eds). The Netherlands, European Society of Clinical Pharmacy. 1997. 51-55. ISBN: 90-74383-15-7.
SALEK, M.S., Finlay, A.Y. & Sumner, M.J. (1997) Impact of intermittent short course cyclosporin therapy on quality of life patients with psoriasis. Quality of Life Research, 6 (7/8), 714.
SALEK, M.S., Finlay, A.Y. & Sumner, M.J. (1997) Long-term cyclosporin treatment improves quality of life in eczema. Quality of Life Research, 6 (7/8), 714.
ALEK, M.S., Jones, H. & Coles, G.A. (1997) Assessment of quality of life in renal patients using the Renal Quality of Life Profile - a validation study. Quality of Life Research, 6(7/8), 714.
SALEK, M.S. (1997) Compendium of quality of life instruments. Quality of Life Research, 6(7/8), 713-714.
Chairojkanjana, K., SALEK, M,S. & Prior, L. (1997) Provision of patient medication records (PMRS) in community pharmacy in Thailand - is it acceptable? Proceedings of the 26th European Symposium on Clinical Pharmacy, Tours. 89.
SALEK, M.S., Ramgoolam, N., Edwards, S.A,, Luscombe, D.K. & Bayer, A.J. (1997) Quality of life assessment in Alzheimer’s disease: reliability of a dementia-specific measure (CDQLP). Proceedings of the 26th European Symposium on Clinical Pharmacy, Tours. 48.
Azzopardi, L.M., Serracino Inglott, A., SALEK, MS. & Zarb Adami, M. (1997) Validation of the intervention of the pharmacist in the care of cancer patients. Proceedings of the 26th European Symposium on Clinical Pharmacy, Tours. 72.
Azzopardi, L.M., Serracino Inglott, A., SALEK, S. & Zarb Adami, M. (1997) Validation of community pharmacy processes: measuring the impact of the pharmacist’s intervention. Proceedings of the 57th International Congress of FIP, Vancouver. 158.
1996
SALEK, M.S., (1996) "Monitoring quality of life post-renal transplant - a measure of effectiveness? In Transplantation" 96 - Maximising Patient Benefit in Transplantation. Johnson, R.W.G. (ed). UK: The Royal Society of Medicine Press. 119-124.
Almuzaini, A.S., SALEK, M.S., Alomar, B.A., and Nicholls, P.J. (1996) Hospice/palliative care services: attitudes, acceptability and the extent of a need in Saudi Arabia. Pharmacy World & Science, 18(5) (Suppl A), A19.
SALEK, M.S., Schwartzberg, A.J., and Bayer, A.J. (1996) Evaluating health-related quality of life in patients with dementia: development of a proxy self-administered questionnaire. Pharmacy World & Science, 18(5) (Suppl A), A6.
SALEK, M.S., Howett, A., and Luscombe, D.K. (1996) Community Pharmacists’ and General Practitioners’ perception of standards of professionalism in community pharmacy practice. Pharmacy World & Science, 18(5) (Suppl A), A18.
SALEK, M.S. and Jinks, M.J. (1996) The United Kingdom: The economy model. In: Health Care Systems Around the World. Lassey, M., Lassey, W., & Jinks, M. (eds). Prentice Hall. 219-239.
SALEK, M.S., Jinks, M.J., and Luscombe, D.K. (1996) International Externship Rotation Scheme (IERS) - the UK experience. Proceedings American Association of Colleges of Pharmacy 97, The Annual Meeting, Reno, USA. 104-105.
SALEK, M.S., McElhone, T.W., and Griffiths, C.E.M. (1996) Assessment of the impact of photo damaged skin on quality of life: a validation study. Proceedings Clinical Dermatology 2000, Vancouver, Canada, 175-176.
SALEK, M.S., Allen, R., Berth-Jones, J., Bleehen, S., Camp, R., Cork, M., Finlay, A.Y., Friedmann, P., Goodyear, H., Graham-Brown, R., Harper, J., Lewis-Jones, S., Smith, S., Tan, B. and Zaki, I. (1996) Cyclosporin improves the quality of life of children with severe eczema and their families. Proceedings Clinical Dermatology 2000, Vancouver, Canada, 173-174.
Allen, B.R., Berth-Jones, J., Bleehen, S.S., Camp, R.D.R., Cork, M.J., Finlay, A.Y., Friedman, P., Goodyear, H., Graham-Brown, R.A.C., Harper, J., Lewis-Jones, S., SALEK, M.S., Smith, S., Tan, B., and Zaki, I. (1996) Cyclosporin in severe childhood atopic dermatitis: a multicentre study. Proceedings Clinical Dermatology 2000, Vancouver, Canada, 96-97.
SALEK, M.S. & Luscombe, D.K. (1996) University of Wales/BrAPP International Training Course in Pharmaceutical Medicine. Pharmaceutical Physician, 8(1), 44-50.
SALEK, M.S. (1996) Quality of life assessment in patients on peritoneal dialysis: a review of the state of the art. Peritoneal Dialysis International, 16(Suppl 1), 6-9.
SALEK, M.S., Khan, G.K. & Finlay, A.Y. (1996) Questionnaire techniques in assessing acne handicap: reliability and validity study. Quality of Life Research, 5(1), 131-138.
SALEK, M.S., Turpin, S., Darby, E., Millar, B., and Maggs, C. (1996) Evaluation of the quality of life of home dialysis patients and their carers: general versus renal-specific measure. In Progress in Clinical Pharmacy. Advanced Activities in Pharmaceutical Care. Netherlands: European Society of Clinical Pharmacy. 123-129. ISBN: 90-74383-11-4.
Blackford, S., Roberts, D.L., SALEK, M.S. & Finlay, A.Y. (1996) Basal cell carcinomas cause little handicap - the reason for delayed presentation. Journal of Quality of Life Research, 5(2), 191-194.
Berth-Jones, J., Finlay, A.Y., Zaki, I., Tan, B., Goodyear, H., Lewis-Jones, S., Cork, M.J., Bleehen, S.S., SALEK, M.S., Allen, B.R., Friedmann, P., Harper, J., Camp, R.D.R., Smith, S. & Graham-Brown, R.A.C. (1996) Cyclosporin in severe childhood atopic dermatitis: a multicentre study. Journal of the American Academy of Dermatology, 34(6), 1016-1021.
1995
Batel-Marques, F.J., Jinks, M.J. and SALEK, M.S. (1995) Perceptions of community pharmacists and family physicians regarding professionalism in community pharmacy practice - a cross-cultural comparison. Proceedings of the Annual Meeting of the American Association of colleges of pharmacy. Philadelphia.
SALEK, M.S., Finlay, A.Y, and Luscombe, D.K. (1995) Are objective clinical measures adequate in understanding the psychosocial behaviour of patients with eczema? European Journal of Clinical Pharmacology, 48(5), A412.
Pritchard, C.J. SALEK, M.S., and Cohen, D.R. (1995) Comparing health status measures: Rosser versus UKSIP. European Journal of Clinical Pharmacology, 48(5), A412.
Price, M.J., Garfunkle, N., SALEK, M.S., Davies, B.H., Walker, S.R. and Luscombe, D.K. (1995) Evaluation of the United Kingdom SIP and SF-36 as measures of quality of life in asthma patients. European Journal of Clinical Pharmacology, 48(5), A412.
Feio, Jose A.L., Batel Marques, F., Borges Alexandrino, F.J. and SALEK, M.S. (1995) Linguistic validation of Portuguese version of the Sickness Impact Profile (PSIP). European Journal of Clinical Pharmacology, 48(5), A417.
Collins, F.G., John, D.N. SALEK, M.S., and Luscombe, D.K. (1995) Influence of home blood glucose monitoring on the quality of life diabetic patients. European Journal of Clinical Pharmacology, 48(5), A417.
Collins, F.G., John, D.N. SALEK, M.S. and Luscombe, D.K. (1995) Therapeutic decision making and the quality of home blood glucose monitoring in diabetic patients. European Journal of Clinical Pharmacology, 48(5), A416.
Blackford, S., Roberts, D.L. SALEK, M.S. and Finlay, A.Y. (1995) Basal cell carcinomas and their treatment cause little handicap - the reason for delayed presentation? Journal of the European Academy of Dermatology and Venereology, 5(Suppl 1), 116.
Feio, A.L.J., Batel Marques, F.J., Borges Alexandrino, and M. SALEK, M.S. (1995) Portuguese cultural adaptation and linguistic validation of the Sickness Impact Profile (PSIP). Quality of Life Research, 4, 424-425.
SALEK, M.S., Turpin, S., Darby, E., Millar, B. and Maggs, C. (1995) Home dialysis - quality of life of patients and impact on carers. Quality of Life Research, 4, 479-480.
Feio, J.A.L., Batel Marques, F.J., Borges, A. and SALEK, M.S. 1995) Patients’ acceptability of health-related quality of life evaluations in routine practice using the Portuguese version of the Sickness Impact Profile (PSIP). PWS Pharmacy World & Science, 17(5) (Suppl J), 21.
SALEK, M.S., Turpin, S., Derby, E., Millar, B. & Maggs, C. (1995) The experience of home dialysis and its impact on the informal carer. PWS Pharmacy World & Science, 17(5) (Suppl. J), 18.
SALEK, M.S. & Walker, M.D. (1995) Quality of life assessment by community pharmacists: its practicality in providing pharmaceutical care. The Pharmaceutical Journal, 255, R28.
Blackford, S., Roberts, D.L. SALEK, M.S. and Finlay, A.Y. (1995) Basal cell carcinomas and their treatment cause little handicap - the reason for delayed presentation? Proceedings of the 6th International Congress on Dermatology & Psychiatry, P71.
SALEK, M.S., Finlay, A.Y., Berth-Jones, J., Zaki, I., Tan, B., Goodyear, H., Lewis-Jones, S., Cork, M., Graham-Brown, R., Allen, R., Friedmann, P., Harper, J., Bleehen, S., Camp, R. and Smith, S. (1995) Effect of cyclosporin on quality of life in severe childhood eczema. Journal of the European Academy of Dermatology and Venereology, 5(Suppl.1), 89-90.
Berth-Jones, J., SALEK, S., Zaki, I., Tan, B., Goodyear, H., Lewis-Jones, S., Cork, M., Graham-Brown, R., Finlay, A., Allen, R., Friedmann, P., Harper, J., Bleehen, S., Camp, R. and Smith, S. (1995) Short-term cyclosporin in severe childhood eczema. Journal of the European Academy of Dermatology and Venereology, 5(Suppl.1), 89.
Blackford, S., Roberts, D.L., SALEK, M.S. and Finlay, A.Y. (1995) Basal cell carcinomas cause little handicap - the reason for delayed presentation? Proceedings American Academy of Dermatology Annual Meeting, New Orleans. 145.
1994
SALEK, M.S. & Luscombe, D.K. (1994) The British approach to the education and training of pharmaceutical physicians. European Journal of Clinical Research, 6, 238-243.
SALEK, M.S. & Godman, B.B. (1994) Socioeconomics in healthcare. In Clinical Research Manual. Luscombe D.K & Stonier, P.D. (eds). England: Euromed Communications. 19.1 - 19.65.
SALEK, M.S., Griffith, A.R., Spiller, C., Luscombe, D.K. & Bayer, A.J. (1994) Assessment of quality of life in patients with dementia - which measure? PWS Pharmacy World & Science, 16(5) (suppl. G), 12.
SALEK, M.S. (1994) Health-related quality of life measurement: a new approach to community care. In Cooperative Care. de Gier J.J. and Knapen, A.F.M. (eds). The Netherlands: PharmaPartners B.V., Oosterhout. 32-47.
SALEK, M.S. (1994) Try a new direction to help relieve eczema: how can effects on patient’s quality of life be assessed? Mims Magazine Weekly, January 25, 18-23.
Berth-Jones, J., Finlay, A., Zaki, I., Tan, B., Goodyear, H., Lowis-Jones, S., Cork, M., Graham-Brown, R., SALEK, S., Allen, R., Friedmann, P., Harper, J., Bleehen, S. & Smith, S., (1994) Cyclosporin in severe childhood atopic dermatitis: a multicentre study. British Journal of Dermatology, 131(suppl. 44), 25.
Blackford, S., Roberts, D.L., SALEK, M.S. & Finlay, A.Y. (1994) Basal cell carcinomas and their treatment cause little handicap - the reason for delayed presentation? Proceedings Skin Therapy Forum II - A Future Look. 23.
SALEK, M.S., Rowsell, R. & Luscombe, D.K. (1994) The BrAPP/UW Postgraduate Course in Pharmaceutical Medicine. Proceedings 8th International Conference on Pharmaceutical Medicine, Rome. 145.
1993
SALEK, M.S., Luscombe, D.K. & Finlay, A.Y. (1993) The impact of cyclosporin A on quality of life in severe refractory psoriasis. Proceedings 52nd Annual Meeting of American Academy of Dermatology, Washington, DC. 165.
SALEK, M.S., Thomas, S., Luscombe, D.K. & Bayer, A.J. (1993) The impact of memory clinic assessment on the quality of life of patients with cognitive decline: sensitivity of the UK Sickness Impact Profile. Pharmaceutisch Weekblad, 15(suppl. 5), 15.
Reakes, A.M., SALEK, M.S., Keggie, J. & Coles, G.A. (1993) Quality of life assessment in haemodialysis patients - when to measure. Nephrology Dialysis Transplantation, 8, 1006-1007.
SALEK, M.S., Finlay, A.Y., Luscombe, D.K., Allen, B.R., Berth-Jones, J., Camp, R.D.R., Graham-Brown, R.A.C., Khan, G.K., Marks, R., Motley, R.J., Ross, J.S. & Sowden, J.M. (1993) Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis - a randomised double-blind, placebo controlled trial. British Journal of Dermatology, 129, 422-430.
SALEK, M.S. & Finlay, A.Y. (1993) Cyclosporin improves quality of life in psoriasis - does this matter? British Journal of Dermatology, 129(suppl. 42), 32-44.
SALEK, M.S. & Finlay, A.Y. (1993) Quality of life improvement in cyclosporin treated patients with psoriasis - an open long term study. Proceedings Dermatology 2000, Vienna, Austria, 139.
SALEK, M.S. (1993) Health-related quality of life measurement. A new challenge for pharmacy practitioners. Journal of Pharmacy and Pharmacology, 45, 387-392.
SALEK, M.S. (1993) Measuring the quality of life in dermatology. In Quality of Life Assesment: Key Issues in the 1990’s. Walker S.R. and Rosser, R.M. (eds). The Netherlands: Kluwer Academic Publishers. 355-370.
1992
SALEK, M.S. & Sclar, D.A. (1992) Medication compliance: the Pharmacist’s Pivotal role. Michigan: Perkins and Associates.
SALEK, M.S. & Luscombe, D.K. (1992) Health-related quality of life assessment: a review. Journal Drug Development, 5, 137-153.
Day, R.D., Jinks, M.J., Abdel-Monem, M.M., Lang, J., SALEK, M.S., Luscombe, D.K., Trisdikoon, P. & Ismail, R. (1992) A pilot study to compare family planning and contraception counselling knowledge and attitudes of senior pharmacy students in Malaysia, Thailand, the United Kingdom and the United States. Proceedings 52nd International Congress of FIP. Lyon, France.
SALEK, M.S., Finlay, A.Y., Khan, G.K. & Luscombe, D.K. (1992) Quality of life in pharmacotherapy: reliability and validity of a general self-scored questionnaire. Pharmaceutisch Weekblad, 14(Suppl E), 23.
SALEK, M.S. (1992) Quality of life assessment in diabetics: the role of quality of life in assessing effective therapy. Pharmaceutisch Weekblad, 14(Suppl E), 19.
SALEK, M.S., Finlay, A.Y., Luscombe, D.K. (1992) Health-related quality of life and clinical assessment - is there a link? Pharmacotherapy, 12, 267.
Batel-Marques, F.J., Walker, R., SALEK, M.S. & Rees, A.J. (1992) Development of a protocol for the operation of a lipid clinic. Pharmacotherapy, 12, 246.
SALEK, M.S., Finlay, A.Y., Khan, G.K., & Luscombe, D.K. (1992) Psychosocial disability and clinical severity of atopic dermatitis - is there a link? Proceedings 4th International Congress on Dermatology and Psychiatry. Philadelphia, USA. 17.
SALEK, M.S., Khan, G.K., & Finlay, A.Y. (1992) Measuring health-related quality of life in patients with psoriasis: reliability of a general and a psoriasis-specific questionnaire. Proceedings 18th World Congress of Dermatology. New York City, USA. 198A.
SALEK, M.S., Finlay, A.Y. & Luscombe, D.K. (1992) Quality of life assessment - its importance as a new pharmacotherapeutic outcome measure. 1st International Congress Therapeutic Drug Monitoring. 61.
1991
SALEK, M.S. (1991) Development, validation and clinical evaluation of a health-related quality of life instrument. CMR News, 9(1), 10-11.
Batel-Marques, F.J., Walker, R., Rees, A., SALEK, M.S., & Luscombe, D.K. (1991) Use of simvastatin in lipid clinic: a preliminary assessment of patient morbidity. Proceedings XXIst Portuguese Pharmacological Society and Xth Clinical Pharmacological Society Meeting, Coimbra. C38.
Sowden, J.M., Berth-Jones, J., Ross, J.S., Motley, R.J., Marks, R. Finlay, A.Y., SALEK, M.S., Graham-Brown, R.A.C., Allen, B.R. & Camp, R.D.R. (1991) Double-blind controlled, Crossover study of cyclosporin in adults with severe refractory atopic dermatitis. The Lancet, 338, 137-140.
Finlay, A.Y., Khan, G.K., SALEK, M.S. (1991) Quality of life measurement - a new dimension in the assessment of skin disease. Proceedings European Academy of Dermatology and Venereology - 2nd Congress. 237.
Khan, G.K., Finlay, A.Y, SALEK, M.S. (1991) Assessment of psychosocial and physical disability in acne patients using self-administered methods. Proceedings 3rd International Congress on Dermatology and Psychiatry. 32.
SALEK, M.S. (1991) Quality of life: the pharmacists’ role. Worldwide Pharmacy Review, 3(5), 1-5.
SALEK, M.S., Peacock, I., Nee, B. & Luscombe, D.K. (1991) Is health-related quality of life assessment important in monitoring patients with diabetes? In Progress in Clinical Pharmacy Muller, N.F., Lacasa, C., Sado P.A. & Walker, R. (eds). The Hague: Amsterdam Medical Press. 65-68.
SALEK, M.S., & Luscombe, D.K. (1991) Cardiovascular disease - a new approach to assessing drug therapy. 2nd Anglo-Egyptian Conference Pharmaceutical Sciences, 28.
SALEK, M.S., Finlay, A.Y., Khan, G.K. & Luscombe, D.K. (1991) Quality of life assessment - its importance as a new pharmacotherapeutic outcome measure. Pharmaceutisch Weekblad, 13(Suppl I), 16.
Malone, M., SALEK, M.S., Luscombe, D.K. & Harris, A.L. (1991) Assessment of health-related quality of life in cancer using the UK Sickness Impact Profile. Pharmaceutical Journal, 247, R50.
Finlay, A.Y., Khan, G.H., SALEK, M.S. & Luscombe, D.K. (1991) The measurement of disability caused by skin disease. Proceedings American Academy of Dermatology, 126.
Berth-Jones, J., Sowden, J., Ross, J., Motley, R., SALEK, M.S., Allen, R., Graham-Brown, R., Marks, R., Camp, R. (1991) Cyclosporin in severe adult atopic dermatitis - a multi-centre, double blind, placebo-controlled, crossover study. British Journal of Dermatology, 125(Suppl 38), 16.
Finlay, A.Y., SALEK, M.S., Khan, G.K., Luscombe, D.K., Allen, R., Berth-Jones, J., Camp, R., Gardener, T., Graham-Brown, R., Marks, R., Motley, R., Ross, J. & Sowden, J. (1991) Quality of life improvement in cyclosporin-treated atopic dermatitis patients: a double blind crossover study. British Journal of Dermatology, 125(Suppl 38), 16.
1990
VandenBurg M.J., SALEK, M.S., Luscombe D.K., Walker, S.R. (1990) The UK Sickness Impact Profile (UKSIP) in cardiovascular disease. Proceedings 7th International Conference on Pharmaceutical Medicine. 50.
SALEK, M.S., Peacock, I., Nee, B. & Luscombe, D.K. (1990) Is health-related quality of life assessment important in monitoring patients with diabetes? Pharmaceutisch Weekbald, 12(Suppl G), 8.
Finlay, A.Y., Khan, G.K., Luscombe, D.K. & SALEK, M.S. (1990) Validation of UK Sickness Impact Profile and Psoriasis Disability Index in psoriasis. British Journal of Dermatology, 123, 751-756.
1989
SALEK, M.S., Enlund, H. (1989) Quality of life - an area of concern for pharmacists? Progress in Clinical Pharmacy. Rational Use of Drugs. The Netherlands: Amsterdam Medical Press. 170-177.
SALEK, M.S., Enlund, H. (1989) Quality of life - an area of concern for pharmacists? Pharmaceutisch Weekblad, 11(5-supp I), 31.
SALEK, M.S., Finlay, A.Y., Khan, G.K., & Luscombe, D.K. (1989) Quality of life measurement in patients with psoriasis? Progress in Clinical Pharmacy. Rational Use of Drugs. The Netherlands: Amsterdam Medical Press. 255-259.
SALEK, M.S., Finlay, A.Y., Khan, G.K., & Luscombe, D.K. (1989) Quality of life measurement in patients with psoriasis. Pharmaceutisch Weekblad, 11, 16.
Finlay, A.Y., SALEK, M.S., Khan, G.K., & Luscombe, D.K. (1989) Psoriasis psychosocial and physical disability assessment using the UK Sickness Impact Profile and Psoriasis Disability Index. Proceedings 2nd International Congress on Dermatology and Psychiatry, Leeds. 45.
1988
SALEK, M.S., & VandenBurg, M.J. (1988) measuring the quality of life in angina Pectoris. Journal for Drug Therapy and Research, 13(5), 186-191.
SALEK, M.S., Walker, S.R., Berry, H. & Luscombe, D.K. (1988) Inflammatory disease and well-being. Proceedings XVIIth European Symposium on Clinical Pharmacy. Leige, Belgium. 61.
SALEK, M.S., Luscombe, D.K., Walker, S.R., Grob, P.R., VandenBurg, M.J. & Lewis, M.J. (1988) Cardiovascular disease and quality of life. British Journal of Clinical Pharmacology, 24, 628P.
SALEK, M.S., Luscombe, D.K., Walker, S.R., Pugh, S. & VandenBurg, M.J. (1988) Quality of life assessment in patients with angina using the UK Sickness Impact Profile (UKSIP). British Journal of Clinical Pharmacology, 25, 99-100.
1987
SALEK, M.S., Luscombe, D.K., Walker, S.R. & VandenBurg, M.J. (1987) Quality of life study in angina patients. Proceedings VIth International Congress of Pharmaceutical Physicians, Brighton. 21P.
ALEK, M.S., Luscombe, D.K., Walker, S.R. & VandenBurg, M.J. (1987) Quality of life in cardiovascular patients. Proceedings XVI European Symposium on Clinical Pharmacy, Annecy, France. 93P.
SALEK, M.S., Luscombe D.K., Walker, S.R., Wiseman, W.T. & VandenBurg, M.J. (1987) Comparing health profiles in patients with angina. Cardiovascular Drug & Therapy, 1, 284.
Berry, H., Bloom, B., SALEK, M.S., Luscombe, D.K. & Walker, S.R. (1987) Quality of life - Does it matter? British Journal of Rheumatology, 26, 123.
SALEK, M.S., Luscombe, D.K., Poston, J.W., Walker, S.R. & VandenBurg, M.J. (1987) Importance of patient involvement in clinical decision making. Proceedings XVI European Symposium on Clinical Pharmacy. Annecy, France, 38P.
1986
SALEK, M.S., Luscombe, D.K., Walker, S.R. & VandenBurg, M.J. (1986) Quality of Life assessment in angina patients. Proceedings XV European Symposium on Clinical Pharmacy, Lisbon, Portugal. A30